Zhai Xiaohan, Wu Guoyu, Tao Xufeng, Yang Shilei, Lv Linlin, Zhu Yanna, Dong Deshi, Xiang Hong
Department of Pharmacy, First Affiliated Hospital of Dalian Medical University Dalian China
Laboratory of Integrative Medicine, First Affiliated Hospital of Dalian Medical University Dalian China.
RSC Adv. 2023 Mar 8;13(12):7798-7817. doi: 10.1039/d3ra00184a.
Microorganisms evolve resistance to antibiotics as a function of evolution. Antibiotics have accelerated bacterial resistance through mutations and acquired resistance through a combination of factors. In some cases, multiple antibiotic-resistant determinants are encoded in these genes, immediately making the recipient organism a "superbug". Current antimicrobials are no longer effective against infections caused by pathogens that have developed antimicrobial resistance (AMR), and the problem has become a crisis. Microorganisms that acquire resistance to chemotherapy (multidrug resistance) are a major obstacle for successful treatments. Pharmaceutical industries should be highly interested in natural product-derived compounds, as they offer new sources of chemical entities for the development of new drugs. Phytochemical research and recent experimental advances are discussed in this review in relation to the antimicrobial efficacy of selected natural product-derived compounds as well as details of synergistic mechanisms and structures. The present review recognizesand amplifies the importance of compounds with natural origins, which can be used to create safer and more effective antimicrobial drugs by combating microorganisms that are resistant to multiple types of drugs.
微生物会随着进化产生对抗生素的耐药性。抗生素通过突变加速了细菌耐药性,并通过多种因素的综合作用产生了获得性耐药。在某些情况下,这些基因中编码了多种抗生素耐药决定因素,这立刻使受体生物体成为“超级细菌”。目前的抗菌药物对已产生抗菌药物耐药性(AMR)的病原体所引起的感染不再有效,这个问题已演变成一场危机。获得化疗耐药性(多药耐药)的微生物是成功治疗的主要障碍。制药行业应该对天然产物衍生的化合物高度关注,因为它们为新药开发提供了新的化学实体来源。本综述讨论了植物化学研究和近期的实验进展,涉及所选天然产物衍生化合物的抗菌功效以及协同机制和结构的细节。本综述认识到并强化了天然来源化合物的重要性,这些化合物可用于对抗对多种药物耐药的微生物,从而制造出更安全、更有效的抗菌药物。